YK-11 is a synthetic steroidal compound studied as a partial androgen receptor agonist with additional reported activity as a myostatin inhibitor, making its proposed mechanism distinct from the nonsteroidal SARMs it is…
🔬 Studied for: Myostatin-Pathway Research
💊 Also studied for: Steroidal-SARM Research
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
YK-11 is a synthetic steroidal compound studied as a partial androgen receptor agonist with additional reported activity as a myostatin inhibitor, making its proposed mechanism distinct from the nonsteroidal SARMs it is often grouped with commercially.
YK-11 is studied for activating the androgen receptor while also increasing expression of follistatin, a protein that inhibits myostatin — a negative regulator of muscle growth — giving YK-11 a proposed dual mechanism distinct from receptor-selective SARMs alone.
These are effects YK-11 has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
In-vitro studies have investigated YK-11's effect on follistatin expression and myostatin inhibition in muscle cell cultures, which is the basis for research-community interest in it as a potentially more potent anabolic signal than androgen receptor activation alone.
Because YK-11 is structurally a steroid rather than the nonsteroidal chemotype of most SARMs, it is sometimes studied separately as a distinct structural class within androgen receptor modulator research.
No dosage of any kind has been clinically validated for YK-11 in humans or animals in vivo. Any protocols circulating in research-community sources are not supported by peer-reviewed in-vivo or clinical trial data.
Compound X does not provide dosing recommendations. YK-11 is sold for laboratory research use only and is not intended for human consumption.
YK-11's published research is limited almost entirely to in-vitro (cell culture) studies rather than animal or human trials. It has no established human safety data, has never been evaluated in human clinical trials, and is not FDA-approved.
No. YK-11 is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Myostatin-Pathway Research — In-vitro studies have investigated YK-11's effect on follistatin expression and myostatin inhibition in muscle cell cultures, which is the basis for research-community interest in it as a potentially more potent anabolic signal than androgen receptor activation alone.
In the US, UK, Canada and Australia, YK-11 is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
YK-11 in-vitro research is indexed on PubMed under search terms such as "YK11 myostatin follistatin androgen receptor."
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.